Researchers examined whether treatment with CD20 inhibitors resulted in worse COVID-19 outcomes among patients with immune-mediated diseases.
All articles by Amit Akirov, MD
Researchers assessed the humoral and cell-mediated immune responses to SARS-CoV-2 mRNA-based vaccines in patients with a history of receiving CD20-targeted B-cell-depleting therapy.
Researchers analyzed the autopsies of patients who died from COVID-19 to understand the pathophysiology of COVID-19-related myopathy.
Authors of a commentary assessed the role of IL-1 receptor antagonism, specifically anakinra, in the treatment of patients with severe COVID-19.
The American Academy of Sleep Medicine provided a position statement on the importance of sleep in health and several objectives to improve health, productivity, and well-being.
Researchers strove to provide robust estimates of incidence rates and relative risks of neurologic and psychiatric diagnoses in patients in the 6 months following a COVID-19 diagnosis.
In correspondence published in The Lancet Neurology, researchers proposed a new definition of adult brain health.
The immunogenicity and safety of SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions receiving immunosuppressive therapy were determined.
Researchers evaluated the contribution of abnormal GI transit to systemic sclerosis Medsger GI severity scores and/or UCLA GIT 2.0 symptoms.